Ventilación líquida

Translated title of the contribution: Liquid ventilation

Antonio R Anzueto, J. Melo, I. Caviedes

Research output: Contribution to journalArticle

Abstract

The use of partial liquid ventilation (PLV) with perfluorocarbons in neonates, children and adults with acute lung injury/acute respiratory distress syndrome is associates with improvement in gas exchange and pulmonary function. Cardiopulmonary interaction with the long-term effects of toxicity requires further study. However, extrapolations from data obtained in animals suggests that no long-term adverse effects exist. The information available indicates that continuous monitoring is required and that ventilador should be adjusted during administration of this drug to reduce hypoxemia, hemodynamic complications and pneumothorax. Further clinical studies are required to explore the efficacy of PLV in acute lung injury/acute respiratory distress syndrome and in particular to determine the short-and long-term toxic effects. To answer these and other questions additional research is undoubtedly required.

Original languageSpanish
Pages (from-to)200-207
Number of pages8
JournalMedicina Intensiva
Volume25
Issue number5
StatePublished - 2001
Externally publishedYes

Fingerprint

Liquid Ventilation
Acute Lung Injury
Adult Respiratory Distress Syndrome
Pulmonary Gas Exchange
Fluorocarbons
Poisons
Pneumothorax
Hemodynamics
Newborn Infant
Research
Pharmaceutical Preparations

Keywords

  • ARDS
  • Liquid ventilation
  • Perfluorocarbon

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine

Cite this

Anzueto, A. R., Melo, J., & Caviedes, I. (2001). Ventilación líquida. Medicina Intensiva, 25(5), 200-207.

Ventilación líquida. / Anzueto, Antonio R; Melo, J.; Caviedes, I.

In: Medicina Intensiva, Vol. 25, No. 5, 2001, p. 200-207.

Research output: Contribution to journalArticle

Anzueto, AR, Melo, J & Caviedes, I 2001, 'Ventilación líquida', Medicina Intensiva, vol. 25, no. 5, pp. 200-207.
Anzueto AR, Melo J, Caviedes I. Ventilación líquida. Medicina Intensiva. 2001;25(5):200-207.
Anzueto, Antonio R ; Melo, J. ; Caviedes, I. / Ventilación líquida. In: Medicina Intensiva. 2001 ; Vol. 25, No. 5. pp. 200-207.
@article{9a1dde1a7b134d2e941387b225351310,
title = "Ventilaci{\'o}n l{\'i}quida",
abstract = "The use of partial liquid ventilation (PLV) with perfluorocarbons in neonates, children and adults with acute lung injury/acute respiratory distress syndrome is associates with improvement in gas exchange and pulmonary function. Cardiopulmonary interaction with the long-term effects of toxicity requires further study. However, extrapolations from data obtained in animals suggests that no long-term adverse effects exist. The information available indicates that continuous monitoring is required and that ventilador should be adjusted during administration of this drug to reduce hypoxemia, hemodynamic complications and pneumothorax. Further clinical studies are required to explore the efficacy of PLV in acute lung injury/acute respiratory distress syndrome and in particular to determine the short-and long-term toxic effects. To answer these and other questions additional research is undoubtedly required.",
keywords = "ARDS, Liquid ventilation, Perfluorocarbon",
author = "Anzueto, {Antonio R} and J. Melo and I. Caviedes",
year = "2001",
language = "Spanish",
volume = "25",
pages = "200--207",
journal = "Medicina Intensiva",
issn = "0210-5691",
publisher = "Ediciones Doyma, S.L.",
number = "5",

}

TY - JOUR

T1 - Ventilación líquida

AU - Anzueto, Antonio R

AU - Melo, J.

AU - Caviedes, I.

PY - 2001

Y1 - 2001

N2 - The use of partial liquid ventilation (PLV) with perfluorocarbons in neonates, children and adults with acute lung injury/acute respiratory distress syndrome is associates with improvement in gas exchange and pulmonary function. Cardiopulmonary interaction with the long-term effects of toxicity requires further study. However, extrapolations from data obtained in animals suggests that no long-term adverse effects exist. The information available indicates that continuous monitoring is required and that ventilador should be adjusted during administration of this drug to reduce hypoxemia, hemodynamic complications and pneumothorax. Further clinical studies are required to explore the efficacy of PLV in acute lung injury/acute respiratory distress syndrome and in particular to determine the short-and long-term toxic effects. To answer these and other questions additional research is undoubtedly required.

AB - The use of partial liquid ventilation (PLV) with perfluorocarbons in neonates, children and adults with acute lung injury/acute respiratory distress syndrome is associates with improvement in gas exchange and pulmonary function. Cardiopulmonary interaction with the long-term effects of toxicity requires further study. However, extrapolations from data obtained in animals suggests that no long-term adverse effects exist. The information available indicates that continuous monitoring is required and that ventilador should be adjusted during administration of this drug to reduce hypoxemia, hemodynamic complications and pneumothorax. Further clinical studies are required to explore the efficacy of PLV in acute lung injury/acute respiratory distress syndrome and in particular to determine the short-and long-term toxic effects. To answer these and other questions additional research is undoubtedly required.

KW - ARDS

KW - Liquid ventilation

KW - Perfluorocarbon

UR - http://www.scopus.com/inward/record.url?scp=0034920339&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034920339&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0034920339

VL - 25

SP - 200

EP - 207

JO - Medicina Intensiva

JF - Medicina Intensiva

SN - 0210-5691

IS - 5

ER -